project: cardiodx

CardioDX logo

Connect with a Sales Specialist

x

CardioDx in the News

The New Wave of Medical Tests That Could Save Your Life

December 10, 2010

Caring.com  

We've all heard the scary stories. Someone in his 40s, seemingly in perfect health, suddenly drops dead during his morning run.

Blood Test for Heart Attack; The Top 10 Everything of 2010

December 09, 2010

TIME  

A heart attack starts with blockages in the blood vessels, so where better to look for predictors of heart trouble than in the blood?

The Winners, Category by Category

September 27, 2010

Wall Street Journal  

This year the Innovation Awards judges chose winners in 17 categories. Here's a look at the winning entries.

Completing the Picture

May 24, 2010

BioCentury  

By teaming up to promote each other's tests for coronary artery disease, CardioDx Inc. and General Electric Co.'s GE Healthcare unit believe they can provide more complete answers to physicians and patients than is possible with either test alone.

CardioDx: Bringing Molecular Diagnostics into the Cardiovascular Arena

March 25, 2010

In Vivo  

Buoyed by their success with Genomic Health, a trio of West Coast VCs have expanded their portfolios of molecular diagnostic companies, with many following similar themes. CardioDx has developed a test to distinguish between patients who should move on to cardiac imaging and those they are comfortable managing otherwise.

Health Watch: Blood Test for Chest Pain

January 13, 2010

FOX News, Atlanta, GA  

Chest pain can be frightening. But doctors now have a new way of diagnosing the heart blockages that may be causing the problem.

CardioDx Launches Gene Test for Obstructive Coronary Disease

September 07, 2009

The Gray Sheet  

CardioDx is gradually rolling out its Corus CAD gene expression test, which quantifies the likelihood of obstructive coronary artery disease in patients with stable chest pain and no previous history of cardiac disease

New Gene Expression Test will make Diagnosing Coronary Artery Disease Simpler

September 01, 2009

HCPLive.com  

CardioDX, a cardiovascular genomic diagnostics company, has completed a multi-center study validating the effectiveness of Corus CAD...

CardioDx Completes Study of Genetic Test for Coronary Artery Disease

September 01, 2009

Diagnostic and Invasive Cardiology  

CardioDx said last week it successfully completed its multicenter validation study for Corus CAD, the first gene expression test to quantify the likelihood of obstructive coronary artery disease (CAD) in patients with stable chest pain.

CardioDx Completes Validation Study of Genomic Test for Coronary Artery Disease

August 26, 2009

Clinical Lab Products  

CardioDx, a cardiovascular genomic diagnostics company, announces that the company has successfully completed its multicenter validation study for Corus CAD, the first and only gene expression test to quantify the likelihood of obstructive coronary artery disease (CAD) in patients with stable chest pain.

1 2 3 4 5